Clinical Trial Update: Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer

View source ↗

Summary

A completed clinical trial investigates multiparametric whole-body MRI as a potential game-changing imaging approach for metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Prostate Cancer (Adenocarcinoma) | Status: COMPLETED